Listed

Xeriant, Inc.: Form 10-Q for the period ended Dec 31, 2019

Filed with the SEC on May 8, 2020 and accepted by EDGAR at May 8, 2020, 16:03 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development6 months2019-07-01 to 2019-12-31$6.3kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2019-10-01 to 2019-12-31−$123.6kus-gaap:OperatingIncomeLoss
Operating income6 months2019-07-01 to 2019-12-31−$141.3kus-gaap:OperatingIncomeLoss
Interest expense3 months2019-10-01 to 2019-12-31−$2.9kus-gaap:InterestExpense
Interest expense6 months2019-07-01 to 2019-12-31−$4.1kus-gaap:InterestExpense
Net income3 months2019-10-01 to 2019-12-31−$277.0kus-gaap:NetIncomeLoss
Net income6 months2019-07-01 to 2019-12-31−$296.2kus-gaap:NetIncomeLoss
Diluted EPS3 months2019-10-01 to 2019-12-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2019-07-01 to 2019-12-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2019-07-01 to 2019-12-31−$150.5kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2019-12-31$176.8kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-12-31$189.4kus-gaap:AssetsCurrent
Total assetsAt period end2019-12-31$419.6kus-gaap:Assets
Current liabilitiesAt period end2019-12-31$277.6kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-12-31$481.0kus-gaap:Liabilities
Shareholders' equityAt period end2019-12-31−$61.4kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001477932-20-002472. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.